I thank you, Mr. McGinnis. I'm very honoured that you would come here today.
This subcommittee is a very special committee, because each and every member in the subcommittee is extremely concerned about brain disorders, neurological disorders, and Parkinson's is a huge piece of that. There are many stories out there like yours, but for you to actually come and talk about what people go through, from the depression to the degeneration of muscles and things like that, it does mean a lot and it helps a lot people. So I want you to know that.
We'll now go into our first round of questions for seven minutes, and we'll begin with Dr. Duncan.